Sitonce
Country: US
Show exams for United States Hong Kong
Sign in

U-500 Insulin: Concentration, Devices, and Dosing Safeguards

Updated 4 min read
Key takeaway

U-500 insulin contains 500 units per milliliter, five times the concentration of U-100 insulin.

More key points
  • Its product label warns of serious dosing errors.
  • A U-500 pen dials the prescribed number of units without conversion; the vial must be used only with a U-500 insulin syringe.
  • Verify the exact product and device and refer any mismatch to the pharmacist.
On this page6 sections
  1. Concentration and dose are different facts
  2. Pen and vial presentations have different instructions
  3. The technician’s verification checks
  4. Patient communication and handoff
  5. Worked example: vial request with a U-100 syringe
  6. Exam takeaway

U-500 insulin is concentrated human insulin. The “500” describes 500 units in each milliliter, compared with 100 units per milliliter in U-100 insulin. The concentration difference makes product selection and device matching critical. The current HUMULIN R U-500 label warns that dispensing, prescribing, or administration errors have caused life-threatening hyperglycemia, hypoglycemia, or death.

Concentration and dose are different facts

Concentration describes how much insulin is present in a given volume. A prescribed dose is expressed in units. Do not convert the ordered dose into milliliters unless the product labeling and pharmacist’s directions specifically require that calculation. For the U-500 KwikPen, the dose window displays insulin units and the patient dials the prescribed number of units; no conversion is needed.

A concentration error can create a fivefold difference in delivered insulin when the wrong device or syringe is used. The product’s own syringe markings are designed for that concentration. Using a U-100 syringe with U-500 vial insulin can lead to dose confusion. The manufacturer’s current label says to use only a U-500 insulin syringe with the vial and not to use another syringe type to administer it.

Pen and vial presentations have different instructions

HUMULIN R U-500 is available as a prefilled KwikPen and as a multi-dose vial. The pen dials a dose in units; its prescribed unit amount is entered directly. The vial is paired with a U-500 syringe. Do not transfer insulin from the pen into a syringe, and do not assume the same handling steps apply across both presentations. Check the exact NDC, strength, package, and device in the prescription.

Packaging helps identify the vial: the current label describes aqua coloring, prominent U-500 statements, and a concentration statement in a green box. Color can support recognition, but it should never replace reading the name and strength. Packages and manufacturers can change, so verify current labeling rather than relying on color memory.

The technician’s verification checks

  • Confirm that the ordered product is U-500 and the intended presentation is pen or vial.
  • Match the prescribed device: U-500 pen for pen orders or the specified U-500 syringe for vial use.
  • Read the insulin name and concentration on the product and dispensing label.
  • Check that the prescribed dose is expressed in units and that no conversion has been added casually.
  • Pause and refer any mismatch, unclear device, or request for a substitute to the pharmacist.
  • Follow the pharmacy’s independent-check and high-alert medication procedures.

The technician should not decide that a U-100 syringe is “close enough,” calculate a conversion from memory, change a pen to a vial, or counsel a patient to alter the dose. If an order is ambiguous, hold the fill and ask the pharmacist to resolve it with the prescriber as needed. This is a high-alert safety check, not a clerical obstacle.

Patient communication and handoff

The product label instructs patients to inspect the insulin label before each injection and to ensure they have the correct brand and concentration. The pharmacist provides patient counseling on device use and the prescribed dose. A technician can confirm that a pharmacist is available for questions and can make sure the right pen or syringe is packaged, but should not teach a new injection technique or adjust the dose independently.

Transitions to a hospital or emergency department deserve careful communication. The product labeling instructs patients to tell staff the U-500 dose prescribed. If a pharmacy learns that the patient has been admitted or that the regimen changed, follow the pharmacist’s process for updating the record and coordinating the correct product information. Do not rely on an old medication list if the prescriber has issued a new order.

Worked example: vial request with a U-100 syringe

A prescription requests HUMULIN R U-500 in a vial, but the supply list shows only U-100 syringes. The technician should not fill the order with the mismatched syringes or calculate markings to make them work. Pause and alert the pharmacist. The pharmacist confirms the product and appropriate U-500 syringe, contacts the prescriber if needed, and documents the resolution before dispensing. If the correct device cannot be supplied, the pharmacy must follow its process for resolving the issue rather than improvise.

Exam takeaway

U-500 is 500 units/mL, five times the concentration of U-100. Match the exact product and device: a U-500 pen dials prescribed units directly; the vial is used only with a U-500 insulin syringe. Verify strength and presentation, avoid informal conversions, and escalate mismatches to the pharmacist.

Common questions

How concentrated is U-500 insulin?

It contains 500 units per milliliter, compared with 100 units per milliliter for U-100 insulin.

Does the U-500 KwikPen require dose conversion?

The current label says to dial and dose the prescribed number of units; no conversion is required.

Can U-500 vial insulin be drawn with a U-100 syringe?

The manufacturer says to use only a U-500 insulin syringe with the U-500 vial. Escalate a device mismatch to the pharmacist.